NantKwest (NK) IPO Prices at $25, Above Expected Range
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
- Qualcomm (QCOM) Reports In-Line Q4 EPS, Beats on Revenue; Offers Q1 Guidance
- Intel shares fall as competitor reports record results
- Array Technologies and Shoals Technologies agree to stock-for-stock merger
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- SanDisk shares fall on election and chip sector pressure
- After-Hours Movers: QCOM, COHR, APP, HUBS, SNAP, FSLY, FIG, ZG, BROS, CDE
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
NantKwest (NK) Gains for Second Session Following Strong IPO
July 29, 2015 11:28 AM EDTNantKwest (Nasdaq: NK) is trading higher for the second session following Tuesday's robust IPO.
Shares of NantKwest are up well over 4 percent. Action comes as NantKwest priced its 8.28 million common stock IPO at $25 per share and opened at $37 yesterday. Shares ended up 38.6 percent higher.
... MoreNantKwest (NK) IPO Opens Up 48%
July 28, 2015 10:38 AM EDTToday's IPO for NantKwest (NASDAQ: NK) opened for trading at $37 after pricing 8,288,000 shares of its common stock at a price to the public of $25 per share, above the expected $20-$23 range. The offering size was raised from 7,000,000 shares.
BofA Merrill Lynch, Citigroup Global Markets Inc., Jefferies LLC and Piper Jaffray are acting as joint book-running managers for the offering, and MLV & Co. LLC is acting as co-manager.
NantKwest is a pioneering, next generation, clinical-stage immunotherapy company focused on harnessing the unique power of our immune system using natural killer (NK) cells to treat... More



